149 related articles for article (PubMed ID: 38820402)
41. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients.
Tatlı Doğan H; Kılıçarslan A; Doğan M; Süngü N; Güler Tezel G; Güler G
Pathol Res Pract; 2016 Nov; 212(11):1021-1026. PubMed ID: 27640103
[TBL] [Abstract][Full Text] [Related]
42. [Time trend analysis of incidence rate for nasopharyngeal carcinoma in urban Shanghai].
Yang WS; Yang C; Zheng JW; Gao J; Zhang W; Zhang ZY; Xiang YB
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1171-4. PubMed ID: 20193589
[TBL] [Abstract][Full Text] [Related]
43. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.
Qiao H; Tan XR; Li H; Li JY; Chen XZ; Li YQ; Li WF; Tang LL; Zhou GQ; Zhang Y; Liang YL; He QM; Zhao Y; Huang SY; Gong S; Li Q; Ye ML; Chen KL; Sun Y; Ma J; Liu N
JAMA Oncol; 2022 Sep; 8(9):1301-1309. PubMed ID: 35834269
[TBL] [Abstract][Full Text] [Related]
44. Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983-2008: suggestion of a potential protective role of oestrogen.
Xie SH; Yu IT; Tse LA; Mang OW; Yue L
Eur J Cancer; 2013 Jan; 49(1):150-5. PubMed ID: 22892061
[TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
See HS; Yap YY; Yip WK; Seow HF
World J Surg Oncol; 2008 Feb; 6():18. PubMed ID: 18275617
[TBL] [Abstract][Full Text] [Related]
46. [The correlation of human papillomavirus and EB virus infection in nasopharyngeal carcinoma in Fujian].
Yang F; Huang S; Wang M; Li J; Chen X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Aug; 28(15):1122-5. PubMed ID: 25322598
[TBL] [Abstract][Full Text] [Related]
47. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
48. Descriptive Study of Nasopharyngeal Carcinoma and Treatment Outcomes: An Eight Years Experience in Hadhramout National Cancer Centre, Yemen.
Bahannan AA; Badheeb AM; Baothman SY
Gulf J Oncolog; 2019 May; 1(30):61-66. PubMed ID: 31242984
[TBL] [Abstract][Full Text] [Related]
49. Association of rhinosinusitis with nasopharyngeal carcinoma: a population-based study.
Hung SH; Chen PY; Lin HC; Ting J; Chung SD
Laryngoscope; 2014 Jul; 124(7):1515-20. PubMed ID: 24114992
[TBL] [Abstract][Full Text] [Related]
50. Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.
Argirion I; Zarins KR; Ruterbusch JJ; Vatanasapt P; Sriplung H; Seymour EK; Rozek LS
Cancer; 2020 Jan; 126(1):121-130. PubMed ID: 31524955
[TBL] [Abstract][Full Text] [Related]
51. Histogram analysis of diffusion kurtosis imaging of nasopharyngeal carcinoma: Correlation between quantitative parameters and clinical stage.
Xu XQ; Ma G; Wang YJ; Hu H; Su GY; Shi HB; Wu FY
Oncotarget; 2017 Jul; 8(29):47230-47238. PubMed ID: 28525383
[TBL] [Abstract][Full Text] [Related]
52. Update on nasopharyngeal carcinoma in northern Israel.
Kuten A; Cohen Y; Lavie R; Dale J; Ben Arush MB; Goldberg H; Stein M
Strahlenther Onkol; 1994 Oct; 170(10):565-70. PubMed ID: 7974167
[TBL] [Abstract][Full Text] [Related]
53. Real World Presentation and Treatment Outcomes with a Predominant Induction Chemotherapy Based Approach in Nasopharyngeal Carcinoma: A Sixteen Year Report from a Teaching Hospital in India.
Gogi R; Sharma A; Sharma A; Mohanti BK; Pramanik R; Bhasker S; Biswas A; Thakar A; Singh AC; Sikka K; Kumar R; Thulkar S; Bahadur S
Cancer Invest; 2023 Feb; 41(2):155-163. PubMed ID: 36305837
[TBL] [Abstract][Full Text] [Related]
54. Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population.
Polesel J; Franceschi S; Talamini R; Negri E; Barzan L; Montella M; Libra M; Vaccher E; Franchin G; La Vecchia C; Serraino D
Oral Oncol; 2011 Jun; 47(6):541-5. PubMed ID: 21478046
[TBL] [Abstract][Full Text] [Related]
55. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
56. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
57. Potential factors associated with clinical stage of nasopharyngeal carcinoma at diagnosis: a case-control study.
Ren JT; Li MY; Wang XW; Xue WQ; Ren ZF; Jia WH
Chin J Cancer; 2017 Sep; 36(1):71. PubMed ID: 28870229
[TBL] [Abstract][Full Text] [Related]
58. Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.
Zeng L; Tian YM; Sun XM; Huang Y; Chen CY; Han F; Liu S; Lan M; Guan Y; Deng XW; Lu TX
Strahlenther Onkol; 2014 Oct; 190(11):993-1000. PubMed ID: 24838409
[TBL] [Abstract][Full Text] [Related]
59. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
60. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.
Liu Z; Li L; Yang Z; Luo W; Li X; Yang H; Yao K; Wu B; Fang W
BMC Cancer; 2010 Jun; 10():270. PubMed ID: 20534121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
